PADI4 and systemic lupus erythematosus: Inhibitors of peptidyl arginine deiminase 4 that mediates citrullination of histones such as BB-Cl-amidine have shown promise in blocking NET formation and inflammation in experimental models of lupus and arthritis [72,73].